Analysts think CNTB stock price could increase by 449%
Jul 27, 2024, 6:26 AM
-17.69%
What does CNTB do
Connect Biopharma Holdings Ltd., headquartered in San Diego, specializes in developing therapies for T cell-driven inflammatory diseases, with key products targeting conditions like atopic dermatitis, asthma, and ulcerative colitis. The company, which went public in 2021, operates globally including in the U.S., China, Europe, Australia, and Hong Kong.
4 analysts think CNTB stock price will increase by 449.23%. The current median analyst target is $7.14 compared to a current stock price of $1.30. The lowest analysts target is $6.06 and the highest analyst target is $8.40.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.